Auro Labs.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE292C01011
  • NSEID:
  • BSEID: 530233
INR
252.50
-2.5 (-0.98%)
BSENSE

Jul 06, 02:17 PM

BSE+NSE Vol: 12.94 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 239365,
    "name": "Auro Labs.",
    "stock_name": "Auro Labs.",
    "full_name": "Auro Laboratories Ltd",
    "name_url": "stocks-analysis/auro-labs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "252.50",
    "chg": -2.5,
    "chgp": "-0.98%",
    "dir": -1,
    "prev_price": "255.00",
    "mcapval": "155.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530233,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE292C01011",
    "curr_date": "Jul 06, 02:17 PM",
    "curr_time": "14:22 PM",
    "last_traded_at": "Jul 06, 02:17 PM IST",
    "bse_nse_vol": "12.94 k",
    "exc_status": "Active",
    "traded_date": "Jul 06, 2026",
    "traded_date_str": "2026 07 06",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/auro-labs-239365-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Auro Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/auro-laboratories-ltd-is-rated-sell-4090671",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AuroLaboratorie_mojoScore_4090671.png",
        "date": "2026-07-06 10:10:31",
        "description": "Auro Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Auro Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/auro-laboratories-ltd-is-rated-sell-4070297",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AuroLaboratorie_mojoScore_4070297.png",
        "date": "2026-06-24 10:10:25",
        "description": "Auro Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Auro Laboratories Declines 8.40% Amid Margin Pressures and Quality Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/auro-laboratories-declines-840-amid-margin-pressures-and-quality-downgrade-4053090",
        "imagepath": "",
        "date": "2026-06-14 14:03:02",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>1 June:</strong> Stock opens at Rs.267.65, down 3.55% amid broader market weakness</p>\n                    <p><strong>3 June:</strong> Quarterly results reveal strong revenue growth but margin pressures</p>\n                    <p><strong>4 June:</strong> Quality rating downgraded to below average, highlighting fundamental concerns</p>\n                    <p><strong>5 June:</strong> Week closes at Rs.254.20, down 1.05% on heavy volume</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.277.50</div></div>\n                    <div class=\"stat-item\"><div class=\"..."
      },
      {
        "title": "Auro Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/auro-laboratories-ltd-is-rated-sell-4048934",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AuroLaboratorie_mojoScore_4048934.png",
        "date": "2026-06-12 10:10:24",
        "description": "Auro Laboratories Ltd is rated Sell by MarketsMOJO, with this rating last updated on 03 June 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 12 June 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Auro Laboratories Ltd Downgraded to Below Average Quality Amid Declining Fundamentals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/auro-laboratories-ltd-downgraded-to-below-average-quality-amid-declining-fundamentals-4035074",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AuroLaboratorie_qualitydot_4035074.png",
        "date": "2026-06-04 08:00:05",
        "description": "Auro Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its quality grading downgraded from Hold to Sell, reflecting a notable deterioration in its business fundamentals. Key financial parameters such as return on equity (ROE), return on capital employed (ROCE), and growth metrics have weakened, raising concerns about the company’s operational efficiency and financial health amid a challenging industry backdrop."
      },
      {
        "title": "Auro Laboratories Ltd Reports Positive Quarterly Growth Amid Margin Pressures",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/auro-laboratories-ltd-reports-positive-quarterly-growth-amid-margin-pressures-4033772",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AuroLaboratorie_fintrenddot_4033772.png",
        "date": "2026-06-03 11:00:06",
        "description": "Auro Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a positive financial performance for the quarter ended March 2026, with robust revenue growth and improved profitability. However, certain operational metrics indicate emerging challenges, prompting a reassessment of its investment grade from Buy to Hold by MarketsMOJO as of 2 March 2026."
      },
      {
        "title": "Auro Laboratories Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/auro-laboratories-ltd-is-rated-hold-4024268",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AuroLaboratorie_mojoScore_4024268.png",
        "date": "2026-05-31 10:10:31",
        "description": "Auro Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 02 Mar 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 31 May 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall market stance."
      },
      {
        "title": "When is the next results date for Auro Laboratories Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-auro-laboratories-ltd-4015055",
        "imagepath": "",
        "date": "2026-05-26 23:18:00",
        "description": "The next results date for Auro Laboratories Ltd is scheduled for 29 May 2026...."
      },
      {
        "title": "Auro Laboratories Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/auro-laboratories-ltd-is-rated-hold-by-marketsmojo-4000748",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AuroLaboratorie_mojoScore_4000748.png",
        "date": "2026-05-20 10:10:37",
        "description": "Auro Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 02 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 May 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      }
    ],
    "total": 168,
    "sid": "239365",
    "stock_news_url": "https://www.marketsmojo.com/news/auro-laboratories-239365"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "30-Jun-2026",
      "details": "Auro Laboratories Limited hereby approve the re-appointment of Mr. Kiran Suresh Kulkarni as a Whole Time Director.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Dated June 30 2026",
      "datetime": "30-Jun-2026",
      "details": "Auro Laboratories Limited scheduled the Board Meeting on June 30 2026 to transact the business matter which are attached herewith.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Jun-2026",
      "details": "Auro Laboratories Limited has informed about the Closure of Trading Window.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Auro Laboratories Declines 8.40% Amid Margin Pressures and Quality Downgrade

2026-06-14 14:03:02

Key Events This Week

1 June: Stock opens at Rs.267.65, down 3.55% amid broader market weakness

3 June: Quarterly results reveal strong revenue growth but margin pressures

4 June: Quality rating downgraded to below average, highlighting fundamental concerns

5 June: Week closes at Rs.254.20, down 1.05% on heavy volume

stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Change in Management

30-Jun-2026 | Source : BSE

Auro Laboratories Limited hereby approve the re-appointment of Mr. Kiran Suresh Kulkarni as a Whole Time Director.

Board Meeting Outcome for Outcome Of The Board Meeting Dated June 30 2026

30-Jun-2026 | Source : BSE

Auro Laboratories Limited scheduled the Board Meeting on June 30 2026 to transact the business matter which are attached herewith.

Closure of Trading Window

26-Jun-2026 | Source : BSE

Auro Laboratories Limited has informed about the Closure of Trading Window.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available